Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Iscience
|
January 2, 2023
A synthetic human 3D <i>in vitro</i> lymphoid model enhancing B-cell survival and functional differentiation
Maaike V J Braham, Rob S van Binnendijk, Anne-Marie M Buisman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 28, 2017
Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
Tom Woudenberg, Rob S van Binnendijk, Elisabeth A M Sanders, et al.
Open Forum Infectious Diseases
|
December 3, 2020
Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose
Patricia Kaaijk, M Alina Nicolaie, Debbie van Rooijen, et al.
Vaccines
|
January 22, 2022
Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults
Patricia Kaaijk, Alienke J Wijmenga-Monsuur, Hinke I Ten Hulscher, et al.
The Lancet. Infectious Diseases
|
September 25, 2019
Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
Laura M Nic Lochlainn, Brechje de Gier, Nicoline van der Maas, et al.
The Journal of Infectious Diseases
|
May 22, 2019
A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults
Patricia Kaaijk, Alienke J Wijmenga-Monsuur, Marlies A van Houten, et al.
Cancers
|
May 13, 2023
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
K L Juliëtte Schmidt, Noël M M Dautzenberg, Peter M Hoogerbrugge, et al.
European Journal of Epidemiology
|
June 11, 2021
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
Scott A McDonald, Fuminari Miura, Eric R A Vos, et al.
Vaccine
|
December 5, 2016
Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
Rory D de Vries, Nella J Nieuwkoop, Mark Pronk, et al.
Travel Medicine and Infectious Disease
|
November 3, 2021
Measles seroprevalence among Dutch travelling families
Laura Doornekamp, Anouskha D Comvalius, Corine H GeurtsvanKessel, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Iscience
|
January 2, 2023
A synthetic human 3D <i>in vitro</i> lymphoid model enhancing B-cell survival and functional differentiation
Maaike V J Braham, Rob S van Binnendijk, Anne-Marie M Buisman, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
January 28, 2017
Large measles epidemic in the Netherlands, May 2013 to March 2014: changing epidemiology
Tom Woudenberg, Rob S van Binnendijk, Elisabeth A M Sanders, et al.
Open Forum Infectious Diseases
|
December 3, 2020
Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose
Patricia Kaaijk, M Alina Nicolaie, Debbie van Rooijen, et al.
Vaccines
|
January 22, 2022
Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults
Patricia Kaaijk, Alienke J Wijmenga-Monsuur, Hinke I Ten Hulscher, et al.
The Lancet. Infectious Diseases
|
September 25, 2019
Immunogenicity, effectiveness, and safety of measles vaccination in infants younger than 9 months: a systematic review and meta-analysis
Laura M Nic Lochlainn, Brechje de Gier, Nicoline van der Maas, et al.
The Journal of Infectious Diseases
|
May 22, 2019
A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults
Patricia Kaaijk, Alienke J Wijmenga-Monsuur, Marlies A van Houten, et al.
Cancers
|
May 13, 2023
Immune Response following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Cancer Patients
K L Juliëtte Schmidt, Noël M M Dautzenberg, Peter M Hoogerbrugge, et al.
European Journal of Epidemiology
|
June 11, 2021
Estimating the asymptomatic proportion of SARS-CoV-2 infection in the general population: Analysis of nationwide serosurvey data in the Netherlands
Scott A McDonald, Fuminari Miura, Eric R A Vos, et al.
Vaccine
|
December 5, 2016
Influenza virus-specific antibody dependent cellular cytoxicity induced by vaccination or natural infection
Rory D de Vries, Nella J Nieuwkoop, Mark Pronk, et al.
Travel Medicine and Infectious Disease
|
November 3, 2021
Measles seroprevalence among Dutch travelling families
Laura Doornekamp, Anouskha D Comvalius, Corine H GeurtsvanKessel, et al.
Page
of 4